Second quarter revenue grew year-over-year, but gross margins and net income declined due to project timing and margin pressure in healthcare and institutional markets. Strong bookings and the CYMCOR acquisition support a diversified growth strategy, though near-term margin headwinds persist.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.